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There was no correlation between the
rates at which the tumours were proliferating
and cellular immune competence.
CELL MEDIATED IMMUNITY IN
CHILDHOOD TUMOURS, S. Kumar,
Christie Hospital, Manchester.
Lymphocytotoxicity tests using the
Hellstr6ms' technique were carried out to
study cell mediated and humoral immunity
in several histological types of childhood
tumour. Tumour type specific lymphocyte
reactivity was detected in most of these
patients; lymphocytes from children Mwith
renal tumours showed a significant cross
reactivity. The degree of lymphocyte
mediated tumour cell killing appeared to be
independent ofthe stage of progression ofthe
tumour. Sera from children with clinically
active tumours blocked the lymphocyto-
toxicity.
A NEW LOOK AT THE EB VIRUS AND
ONCOGENESIS, R. N. P. Sutton, Depart-
ment ofMicrobiology, King's College Hospital
Medical School, London.
The EB virus, a herpes-like DNA virus,
has been associated with malignant disease
(Burkitt's lymphoma, nasopharyngeal carci-
noma) and with infectious mononucleosis and
asymptomatic infections. Spiegelman and
his colleagues (Proc. natn. Acad. Sci. U.S.A.,
1973, 70, 5) have recently detected nucleic
acid homologous with that of the RNA
Rauscher murine leukaemia virus in Burkitt's
lymphoma and nasopharyngeal carcinoma
cells.
This apparent conflict may be resolved
bythe assumption that the temporary depres-
sion of cell mediated immunity which occurs
with EB infection in infectious mono-
nucleosis also occurs in asymptomatic infec-
tions and is the necessary stimulus which
activates an otherwise dormant RNA virus
genome.
Sixty-eight children with acute lympho-
blastic leukaemia were tested for antibodies
to commonly encountered viruses, including
the EB virus; their antibody responses were
normal, indicating intact humoral immunity.
In the case of the EB virus, the antibody
pattern in children tested during the first
month of their leukaemic illness suggested
that a high proportion had experienced
infection with this virus. In view of the
potential immunosuppressive properties of
the EB virus, it is suggested that these
findings mav be related to the leukaemogenic
process.
INDEPENDENT RESPONSES OF
DIFFERENT BINDING SITES ON
EHRLICH ASCITES TUMOUR CELLS
TO TRYPSIN AND TRYPSIN IN-
HIBITOR, P. Whur, Noreen E. Payne and
H. Koppel, The Marie Curie Memorial
Foundation, Oxted.
We previously reported (Whur, Robson
and Payne, Br. J. Cancer, 1973, 28, 80) that
Ehilich ascites tumour cells do not adhere to
mouse host intraperitoneal surfaces unless
treated wvith soybean trypsin inhibitor.
We have subsequently found that the
binding of these cells to NCTC clone 929
mouse cell monolayers in vitro is significantly
enhanced in the presence oftrypsin inhibitor.
However, under the same conditions, adhesion
to plastic surfaces is inhibited by trypsin
inhibitor. Furthermore, incubationoftumour
cells in very low concentrations of trypsin
significantly enhances their adhesion to
plastic surfaces.
These findings suggest that the degree to
wrhich binding sites are expressed is altered by
increasing or decreasing proteolysis of cell
surface components, and that altered proteo-
lysis may suppress the expression of one site
while simultaneously enhancing another.
ULTRASTRUCTURAL AND BIO-
CHEMICAL STUDIES OF THE
EFFECTS OF CONCANAVALIN A ON
LANDSCHUTZ ASCITES TUMOUR
(LAT) CELLS, R. G. P. Pugh-Humphreys
and D. Lawson, Department of Zoology,
University of Aberdeen.
Concanavalin A, a protein which binds
terminal non-reducing o-methyl-D-manno-
pyranosides and o-methyl-D-glucopyrano-
sides (Goldstein, Lucy and Yang, J. Immun.,
1969, 103, 695), agglutinates and induces
functional changes in a variety of cells
(Sharon and Lis, Science, N.Y., 1972, 177,
949) and is cytotoxic to ascites tumour cells
(Inbar, Ben-Basset and Saclis, Int. J. Cancer,
1972, 9, 143).
Concanavalin A treatment of LAT cells
resulted in marked cell agglutination, stimu-
lated 02 uptake and pinocytotic activity
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swelling and rupture of mitochondria and a
reduction in ATP/ADP ratio compared with
untreated cells. These effects ofconcanavalin
A were markedly reduced by oc-methyl-D-
mannopyranoside, indicating that the conca-
navalin A binding sites on the LAT cells are
sterically related to this sugar. The observed
effects on the mitochondria may provide an
explanation for the known cytotoxic effect of
concanavalin A on ascites tumour cells.
ACCENTUATION OF CHLORAM-
BUCIL EFFECT BY VARIOUS ADDI-
TIVES ON RAT TUMOUR CELLS IN
CULTURE, T. K. Basu, N. P. Bishun,
R. W. Raven and D. C. Williams, The Marie
Curie Memorial Foundation, Oxted.
Chlorambucil has been used extensively
for the treatment of chronic lymphoblastic
leukaemia but the development of resistance
to the drug has restricted its usefulness. An
understanding of its mode of action when
used in combination with other substances
may lead to a wider application of the drug
in cancer therapy. In recent years vitamin
A and caffeine have been reported to enhance
the anti-tumour effect of certain alkylating
agents (Cohen and Carbone, J. natn. Cancer
Inst., 1972, 48, 921; Cohen, J. natn. Cancer
Inst., 1972, 48, 927).
In view of these observations, we have
investigated the combined effect of chloram-
bucil, vitamin A, caffeine and phenobarbitone
on an established tumour cell line derived
from a male rat breast. The viable cell
counts in chlorambucil (Chl), Chl + pheno-
barbitone (Pb), Chl + Pb + caffeine (Caf)
and Chl + Pb + Caf + vitamin A were610%,
4400, 40% and 25% of the control counts
respectively after 3 days, at which time these
combinations had their greatest efficacy.
FACTORS INFLUENCING THE ES-
TABLISHMENT OF HUMAN TU-
MOUR CELLS AS A XENOGRAFT,
L. M. Cobb, B. C. V. Mitchley and J. M. F.
Wood, Huntingdon Research Centre and
Chester Beatty Research Institute, London.
In recent years it has been possible to
obtain growth of human tumours in
" immune deprived " rodents. We have
observed that certain types of tumour, for
example, carcinoma ofthe colon and rectum,
almost invariably become established and
others have proved difficult to grow. During
this work a number of factors have emerged
that seem likely to influence the establish-
ment ofhuman tumour grafts. These factors
include species of recipient, method of
immune deprivation, blood levels of sex
hormones in the recipient and size and site of
implant.
CHLORPROMAZINE STIMULATION
OF PROLACTIN SECRETION: A
TEST OF PITUITARY FUNCTION,
R. G. Wilson, B. N. Cole, A. R. Boyns and
A. P. M. Forrest, Department of Clinical
Surgery, University of Edinburgh and Teno-
vus Institute of Cancer Research, Cardiff.
Phenothiazines cause a rise in plasma
prolactin in normal subjects when given
orally or by injection (Frantz et al. and
Bryant and Greenwood, 1972. Ciba Sym-
posium Lactogenic Hormones. Ed. G. B. W.
Wolstenholme and J. Knight. London and
Edinburgh: Churchill Livingstone). Turking-
ton (J. clin. Endocr. 1972, 34, 247) described
the acute stimulation of prolactin secretion
using 50 mg of chlorpromazine i.m. The
prolactin response was diminished in hypo-
pituitarism.
Six patients with breast cancer were
similarly tested. The plasma prolactin
response was measured by homologous radio-
immunoassay. The mean basal plasma
prolactin was 13-7 + (s.e.) 7-5 mAmp/ml.
This rose to a peak of 77-3 ± 11-4 mAmp/ml
within 2 hours of the injection.
One to three months after yttrium
implant pituitary ablation for advanced
breast cancer, patients received a similar
stimulation ofresidual prolactin cell function.
This was in addition to the standard test of
growth hormone response to insulin reduced
hypoglycaemia (Stewart et al., J. Endocr.,
1971, 50, 41). The two tests have been
compared and both have demonstrated
positive responses in the case of incomplete
pituitary ablation, as proven by post-mortem
histology of the gland.
The chlorpromazine test is simple and
possibly safer than the standard test in
hypophysectomized patients.
THE EFFECTS OF FENTAZIN ON
ANDROGEN METABOLISM IN DMBA
INDUCED RAT ADENOCARCINO-
MATA, W. R. Miller, R. Buchan and
A. P. M. Forrest, Department of Clinical
Surgery, University of Edinburgh.